Macquillan GC - Search Results

1

Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin.

Lee S, Macquillan GC, Keane NM, Flexman J, Jeffrey GP, French MA, Brochier J, Price P. Lee S, et al. Among authors: macquillan gc. Immunol Cell Biol. 2002 Aug;80(4):391-7. doi: 10.1046/j.1440-1711.2002.01102.x. Immunol Cell Biol. 2002. PMID: 12121229 Clinical Trial.

2

Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care.

Clark PJ, Valery PC, Strasser SI, Weltman M, Thompson A, Levy MT, Leggett B, Zekry A, Rong J, Sinclair M, George J, Bollipo S, McGarity B, Sievert W, MacQuillan G, Tse E, Nicoll A, Wade A, Cheng W, Roberts SK. Clark PJ, et al. J Gastroenterol Hepatol. 2024 Mar;39(3):568-575. doi: 10.1111/jgh.16440. Epub 2023 Dec 19. J Gastroenterol Hepatol. 2024. PMID: 38114452

3

Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.

MacQuillan GC, de Boer WB, Platten MA, McCaul KA, Reed WD, Jeffrey GP, Allan JE. MacQuillan GC, et al. J Med Virol. 2002 Oct;68(2):197-205. doi: 10.1002/jmv.10182. J Med Virol. 2002. PMID: 12210408

4

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.

Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G. Rossi E, et al. Clin Chem. 2003 Mar;49(3):450-4. doi: 10.1373/49.3.450. Clin Chem. 2003. PMID: 12600957

5

Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.

MacQuillan GC, Mamotte C, Reed WD, Jeffrey GP, Allan JE. MacQuillan GC, et al. J Med Virol. 2003 Jun;70(2):219-27. doi: 10.1002/jmv.10381. J Med Virol. 2003. PMID: 12696108

6

Outcome, tolerability and compliance of compassionate use interferon and ribavirin for hepatitis C infection in a shared care hospital clinic.

Kontorinis N, Garas G, Young J, Speers D, Chester BP, MacQuillan GC, De Boer B, Chapman MD, Forster E, Jeffrey GP. Kontorinis N, et al. Among authors: macquillan gc. Intern Med J. 2003 Nov;33(11):500-4. doi: 10.1046/j.1445-5994.2003.00410.x. Intern Med J. 2003. PMID: 14656252

7

Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?

Macquillan GC, Niu X, Speers D, English S, Garas G, Harnett GB, Reed WD, Allan JE, Jeffrey GP. Macquillan GC, et al. J Gastroenterol Hepatol. 2004 May;19(5):551-7. doi: 10.1111/j.1440-1746.2003.03319.x. J Gastroenterol Hepatol. 2004. PMID: 15086599

8

Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants.

Jeffrey GP, MacQuillan G, Chua F, Galhenage S, Bull J, Young E, Hulse G, O'Neil G. Jeffrey GP, et al. Hepatology. 2007 Jan;45(1):111-7. doi: 10.1002/hep.21470. Hepatology. 2007. PMID: 17187435 Clinical Trial.

9

Urgent liver transplantation for acute liver failure due to parvovirus B19 infection complicated by primary Epstein-Barr virus and cytomegalovirus infections and aplastic anaemia.

So K, Macquillan G, Garas G, Delriviere L, Mitchell A, Speers D, Mews C, Augustson B, de Boer WB, Baker D, Jeffrey GP. So K, et al. Intern Med J. 2007 Mar;37(3):192-5. doi: 10.1111/j.1445-5994.2006.01293.x. Intern Med J. 2007. PMID: 17316340

10

Levetiracetam as a possible cause of fulminant liver failure.

Tan TC, de Boer BW, Mitchell A, Delriviere L, Adams LA, Jeffrey GP, Macquillan G. Tan TC, et al. Neurology. 2008 Aug 26;71(9):685-6. doi: 10.1212/01.wnl.0000324604.11657.c6. Neurology. 2008. PMID: 18725594 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters